echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 2017 blue book on the development of China's biomedical industry was officially released focusing on industry development path and experience (Firestone creation)

    2017 blue book on the development of China's biomedical industry was officially released focusing on industry development path and experience (Firestone creation)

    • Last Update: 2018-08-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On August 6, 2018, Flint creation officially released the 2017 blue book on the development of China's biomedical industry The blue book was compiled by flint creation research, and used flint to create the independently developed Spider intelligent data source construction system and Darwin The data intelligent processing engine systematically studies and analyzes the development status and trend of biomedical industry, combs the development path of global key biomedical industry clusters and domestic typical industrial parks, puts forward suggestions for the development of China's biomedical industry, and provides guidance and reference for the industrial main management departments and practitioners at all levels According to the blue book, the global biomedical market shows a strong growth trend far higher than the global economic growth rate Under the two-way drive of technological progress and demand growth, the biomedical industry will usher in a golden age of development Global competition will continue to intensify Developed countries and emerging countries have increased their codes Large enterprises merge and acquire small and medium-sized enterprises to promote the market concentration and innovation in the frontier biotechnology field Based on the research on the development advantages and successful experience of key biomedical clusters in the United States, such as Boston, Israel and Japan, it is found that as a talent intensive and knowledge intensive industry, the development of biomedical industry has a natural basis for regional cluster development In the future, with the rise of biomedicine to national strategy, biomedical industry cluster will accelerate the development, promote the effective gathering of social resources, promote the highly coordinated development of the whole industry chain, reduce the risk of biomedical innovation and entrepreneurship, and improve the efficiency of product commercialization From the domestic point of view, the biomedical industry is mainly distributed in the Yangtze River Delta, Pearl River Delta and Bohai rim regions Among them, Beijing Zhongguancun National Independent Innovation Demonstration Zone, Zhang Jiang pharmaceutical Valley, Suzhou biological medicine Industrial Park (BioBAY), Wuhan Optics Valley biological city and other parks have become the most representative and advanced biomedical industry gathering areas in China Through combing the development mode of domestic advanced parks, we can see that the development mode of biomedical industry is composed of technology, market, talent, capital, enterprise and government How to highlight innovation driving and maximize the value of industrial services is the key problem to be solved in industrial development Therefore, the blue book focuses on Zhangjiang pharmaceutical Valley and Suzhou biomedical industrial park (BioBAY) as typical cases, analyzes the development mode and path of cultivating biomedical industry in the two parks, from which we can see the value embodiment of the two parks in the innovation and development of China's biomedical industry Finally, based on the characteristics and development trend of biomedical industry, combined with the successful experience of global biomedical industry cluster development and China's industrial development environment and characteristics, the blue book puts forward countermeasures and suggestions for the industrial development of China's biomedical park in three aspects of "characteristic cluster", "scientific and technological innovation" and "financial support": 1 Strengthen the macro top-level design and create the characteristic industrial cluster: strengthen the overall planning and layout to realize the differential development; build the regional characteristic industrial park to form the characteristic industry; cultivate the regional key advantage brand to enhance the brand influence; 2 Build the industrial innovation system to improve the industrial development level To build a technological innovation system with enterprise as the main body, market as the guide and combination of production, learning and research, strengthen the guidance of technological innovation, strengthen the construction of innovation environment, and ensure the real transformation of innovation achievements; 3 To increase the financial support to ensure the development of technological innovation Strengthen financial support and guidance, improve the effectiveness of the project, improve the financial support system, and enhance the support of small and medium-sized innovative enterprises The author of this blue book, Fang Huoshi, takes "accelerating medical innovation and entrepreneurship, everyone enjoys a healthy life" as his mission, and based on perfect data and advanced algorithm model, is the world's first health industry brain, enabling governments, industrial parks, life and health enterprises and financial institutions, so as to realize data and intelligent insight into industry, layout industry and develop industry In addition, Deloitte, one of the four largest accounting firms in the world, also provides valuable opinions and suggestions for the compilation of the blue book.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.